Oxidative stress and antioxidants in the pathophysiology of malignant melanoma

References

Aghajanian, A., Wittchen, E.S., Campbell, S.L., and Burridge, K. (2009). Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 4, e8045.10.1371/journal.pone.0008045Suche in Google Scholar PubMed PubMed Central

Ahmed, B. and Van Den Oord, J.J. (1999). Expression of the neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin. Br. J. Dermatol. 141, 12–19.10.1046/j.1365-2133.1999.02915.xSuche in Google Scholar PubMed

Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A.J.R., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Børresen-Dale, A.-L., et al. (2013). Signatures of mutational processes in human cancer. Nature 500, 415–421.10.1038/nature12477Suche in Google Scholar PubMed PubMed Central

Allen, J.F. (1993). Control of gene expression by redox potential and the requirement for chloroplast and mitochondrial genomes. J. Theor. Biol. 165, 609–631.10.1006/jtbi.1993.1210Suche in Google Scholar PubMed

Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330, 1029–1035.10.1056/NEJM199404143301501Suche in Google Scholar PubMed

Asensi, M., Sastre, J., Pallardó, F.V., García de la Asunción, J., Estrela, J.M., and Viña, J. (1994). A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal. Biochem. 217, 323–328.10.1006/abio.1994.1126Suche in Google Scholar PubMed

Assi, M. (2017). The differential role of reactive oxygen species in early and late stages of cancer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 313, R646–R653.10.1152/ajpregu.00247.2017Suche in Google Scholar PubMed

Avery-Kiejda, K.A., Bowden, N.A., Croft, A.J., Scurr, L.L., Kairupan, C.F., Ashton, K.A., Talseth-Palmer, B.A., Rizos, H., Zhang, X.D., Scott, R.J., et al. (2011). P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation. BMC Cancer 11, 203.10.1186/1471-2407-11-203Suche in Google Scholar PubMed PubMed Central

Bachi, A.L.L., Kim, F.J.K., Nonogaki, S., Carneiro, C.R.W., Lopes, J.D., Jasiulionis, M.G., and Correa, M. (2009). Leukotriene B4 creates a favorable microenvironment for murine melanoma growth. Mol. Cancer Res. MCR 7, 1417–1424.10.1158/1541-7786.MCR-09-0038Suche in Google Scholar PubMed

Balkwill, F.R., Capasso, M., and Hagemann, T. (2012). The tumor microenvironment at a glance. J. Cell Sci. 125, 5591–5596.10.1242/jcs.116392Suche in Google Scholar PubMed

Bandarchi, B., Ma, L., Navab, R., Seth, A., and Rasty, G. (2010). From melanocyte to metastatic malignant melanoma. Dermatol. Res. Pract. 2010. pii: 583748.10.1155/2010/583748Suche in Google Scholar

Benlloch, M., Mena, S., Ferrer, P., Obrador, E., Asensi, M., Pellicer, J.A., Carretero, J., Ortega, A., and Estrela, J.M. (2006). Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J. Biol. Chem. 281, 69–79.10.1074/jbc.M507471200Suche in Google Scholar

Benlloch, M., Obrador, E., Valles, S.L., Rodriguez, M.L., Sirerol, J.A., Alcácer, J., Pellicer, J.A., Salvador, R., Cerdá, C., Sáez, G.T., et al. (2016). Pterostilbene decreases the antioxidant defenses of aggressive cancer cells in vivo: a physiological glucocorticoids- and Nrf2-dependent mechanism. Antioxid. Redox Signal. 24, 974–990.10.1089/ars.2015.6437Suche in Google Scholar

Benz, C.C., Atsriku, C., Yau, C., Britton, D., Schilling, B., Gibson, B.W., Baldwin, M.A., and Scott, G.K. (2006). Novel pathways associated with quinone-induced stress in breast cancer cells. Drug Metab. Rev. 38, 601–613.10.1080/03602530600959391Suche in Google Scholar

Bernardes, S.S., de Souza-Neto, F.P., Ramalho, L.N.Z., Derossi, D.R., Guarnier, F.A., da Silva, C.F.N., Melo, G.P., Simão, A.N.C., Cecchini, R., and Cecchini, A.L. (2015). Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients. Cancer Lett. 361, 226–232.10.1016/j.canlet.2015.03.007Suche in Google Scholar

Besedovsky, H.O., del Rey, A., Klusman, I., Furukawa, H., Monge Arditi, G., and Kabiersch, A. (1991). Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40, 613–618.10.1016/0960-0760(91)90284-CSuche in Google Scholar

Bethin, K.E., Vogt, S.K., and Muglia, L.J. (2000). Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. USA 97, 9317–9322.10.1073/pnas.97.16.9317Suche in Google Scholar PubMed PubMed Central

Bienert, G.P., Schjoerring, J.K., and Jahn, T.P. (2006). Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta 1758, 994–1003.10.1016/j.bbamem.2006.02.015Suche in Google Scholar PubMed

Bienert, G.P., Møller, A.L.B., Kristiansen, K.A., Schulz, A., Møller, I.M., Schjoerring, J.K., and Jahn, T.P. (2007). Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282, 1183–1192.10.1074/jbc.M603761200Suche in Google Scholar PubMed

Bisevac, J.P., Djukic, M., Stanojevic, I., Stevanovic, I., Mijuskovic, Z., Djuric, A., Gobeljic, B., Banovic, T., and Vojvodic, D. (2018). Association between oxidative stress and melanoma progression. J. Med. Biochem. 37, 12–20.10.1515/jomb-2017-0040Suche in Google Scholar PubMed PubMed Central

Bittinger, F., González-García, J.L., Klein, C.L., Brochhausen, C., Offner, F., and Kirkpatrick, C.J. (1998). Production of superoxide by human malignant melanoma cells. Melanoma Res. 8, 381–387.10.1097/00008390-199810000-00001Suche in Google Scholar

Borovanský, J. and Elleder, M. (2003). Melanosome degradation: fact or fiction. Pigment Cell Res. 16, 280–286.10.1034/j.1600-0749.2003.00040.xSuche in Google Scholar

Borovansky, J. and Riley, P.A. (2011). Melanins and Melanosomes: Biosynthesis, Structure, Physiological and Pathological Functions (Hoboken, NJ, USA: John Wiley & Sons).10.1002/9783527636150Suche in Google Scholar

Bracalente, C., Ibañez, I.L., Berenstein, A., Notcovich, C., Cerda, M.B., Klamt, F., Chernomoretz, A., and Durán, H. (2016). Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated. Oncotarget 7, 41154–41171.10.18632/oncotarget.9273Suche in Google Scholar

Brozmanová, J., Mániková, D., Vlčková, V., and Chovanec, M. (2010). Selenium: a double-edged sword for defense and offence in cancer. Arch. Toxicol. 84, 919–938.10.1007/s00204-010-0595-8Suche in Google Scholar

Bücher, T., Brauser, B., Conze, A., Klein, F., Langguth, O., and Sies, H. (1972). State of oxidation-reduction and state of binding in the cytosolic NADH-system as disclosed by equilibration with extracellular lactate-pyruvate in hemoglobin-free perfused rat liver. Eur. J. Biochem. 27, 301–317.10.1111/j.1432-1033.1972.tb01840.xSuche in Google Scholar

Burdon, R.H. (1995). Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18, 775–794.10.1016/0891-5849(94)00198-SSuche in Google Scholar

Cameron, E. and Pauling, L. (1976). Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA 73, 3685–3689.10.1073/pnas.73.10.3685Suche in Google Scholar PubMed PubMed Central

Cameron, E. and Pauling, L. (1978). Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA 75, 4538–4542.10.1073/pnas.75.9.4538Suche in Google Scholar PubMed PubMed Central

Carretero, J., Obrador, E., Anasagasti, M.J., Martin, J.J., Vidal-Vanaclocha, F., and Estrela, J.M. (1999). Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin. Exp. Metastasis 17, 567–574.10.1023/A:1006725226078Suche in Google Scholar

Carretero, J., Obrador, E., Esteve, J.M., Ortega, A., Pellicer, J.A., Sempere, F.V., and Estrela, J.M. (2001). Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J. Biol. Chem. 276, 25775–25782.10.1074/jbc.M101148200Suche in Google Scholar PubMed

Cassidy, P.B., Fain, H.D., Cassidy, J.P., Tran, S.M., Moos, P.J., Boucher, K.M., Gerads, R., Florell, S.R., Grossman, D., and Leachman, S.A. (2013). Selenium for the prevention of cutaneous melanoma. Nutrients 5, 725–749.10.3390/nu5030725Suche in Google Scholar PubMed PubMed Central

Chen, K.G., Leapman, R.D., Zhang, G., Lai, B., Valencia, J.C., Cardarelli, C.O., Vieira, W.D., Hearing, V.J., and Gottesman, M.M. (2009). Influence of melanosome dynamics on melanoma drug sensitivity. J. Natl. Cancer Inst. 101, 1259–1271.10.1093/jnci/djp259Suche in Google Scholar PubMed PubMed Central

Cheng, G., Diebold, B.A., Hughes, Y., and Lambeth, J.D. (2006). Nox1-dependent reactive oxygen generation is regulated by Rac1. J. Biol. Chem. 281, 17718–17726.10.1074/jbc.M512751200Suche in Google Scholar PubMed

Chio, I.I.C. and Tuveson, D.A. (2017). ROS in cancer: the burning question. Trends Mol. Med. 23, 411–429.10.1016/j.molmed.2017.03.004Suche in Google Scholar PubMed PubMed Central

Chiou, Y.-S., Tsai, M.-L., Nagabhushanam, K., Wang, Y.-J., Wu, C.-H., Ho, C.-T., and Pan, M.-H. (2011). Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J. Agric. Food Chem. 59, 2725–2733.10.1021/jf2000103Suche in Google Scholar PubMed

Choudhari, S.K., Chaudhary, M., Bagde, S., Gadbail, A.R., and Joshi, V. (2013). Nitric oxide and cancer: a review. World J. Surg. Oncol. 11, 118.10.1186/1477-7819-11-118Suche in Google Scholar PubMed PubMed Central

Church, S.L., Grant, J.W., Ridnour, L.A., Oberley, L.W., Swanson, P.E., Meltzer, P.S., and Trent, J.M. (1993). Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. USA 90, 3113–3117.10.1073/pnas.90.7.3113Suche in Google Scholar PubMed PubMed Central

Cifuentes-Pagano, E., Meijles, D.N., and Pagano, P.J. (2014). The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls. Antioxid. Redox Signal. 20, 2741–2754.10.1089/ars.2013.5620Suche in Google Scholar PubMed PubMed Central

Collisson, E.A., De, A., Suzuki, H., Gambhir, S.S., and Kolodney, M.S. (2003). Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade. Cancer Res. 63, 5669–5673.Suche in Google Scholar

Comito, G., Calvani, M., Giannoni, E., Bianchini, F., Calorini, L., Torre, E., Migliore, C., Giordano, S., and Chiarugi, P. (2011). HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic. Biol. Med. 51, 893–904.10.1016/j.freeradbiomed.2011.05.042Suche in Google Scholar PubMed

Curran, R.C. and McCann, B.G. (1976). The ultrastructure of benign pigmented naevi and melanocarcinomas in man. J. Pathol. 119, 135–146.10.1002/path.1711190303Suche in Google Scholar PubMed

D’Andrea, G.M. (2005). Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA. Cancer J. Clin. 55, 319–321.10.3322/canjclin.55.5.319Suche in Google Scholar PubMed

Davies, K.J. (2000). Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 50, 279–289.10.1080/15216540051081010Suche in Google Scholar

Davies, J.M.S., Cillard, J., Friguet, B., Cadenas, E., Cadet, J., Cayce, R., Fishmann, A., Liao, D., Bulteau, A.-L., Derbré, F., et al. (2017). The Oxygen Paradox, the French Paradox, and age-related diseases. GeroScience 39, 499–550.10.1007/s11357-017-0002-ySuche in Google Scholar PubMed PubMed Central

Davila-Gonzalez, D., Rosato, R.R., Qian, W., Kozielski, A.J., Chen, W., Choi, D.S., Dave, B., Kranjac, D., Ensor, J.E., and Chang, J.C. (2017). Abstract LB-196: evaluation of anti PD-1 plus nitric oxide synthase inhibition combination therapy in 12 triple-negative breast cancer patient-derived xenografts using a human-derived immune system model. Cancer Res. 77, LB-196-LB-196.10.1158/1538-7445.AM2017-LB-196Suche in Google Scholar

Dellinger, R.W., Matundan, H.H., Ahmed, A.S., Duong, P.H., and Meyskens, F.L. (2012). Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells. PLoS One 7, e47696.10.1371/journal.pone.0047696Suche in Google Scholar PubMed PubMed Central

Denat, L., Kadekaro, A.L., Marrot, L., Leachman, S.A., and Abdel-Malek, Z.A. (2014). Melanocytes as instigators and victims of oxidative stress. J. Invest. Dermatol. 134, 1512–1518.10.1038/jid.2014.65Suche in Google Scholar PubMed PubMed Central

DeNicola, G.M., Karreth, F.A., Humpton, T.J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K.H., Yeo, C.J., Calhoun, E.S., et al. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106–109.10.1038/nature10189Suche in Google Scholar PubMed PubMed Central

Eberle, J. and Hossini, A.M. (2008). Expression and function of bcl-2 proteins in melanoma. Curr. Genomics 9, 409–419.10.2174/138920208785699571Suche in Google Scholar PubMed PubMed Central

Ekmekcioglu, S., Ellerhorst, J., Smid, C.M., Prieto, V.G., Munsell, M., Buzaid, A.C., and Grimm, E.A. (2000). Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 6, 4768–4775.Suche in Google Scholar

Ekmekcioglu, S., Grimm, E.A., and Roszik, J. (2017). Targeting iNOS to increase efficacy of immunotherapies. Hum. Vaccines Immunother. 13, 1105–1108.10.1080/21645515.2016.1276682Suche in Google Scholar PubMed PubMed Central

Ekshyyan, O. and Aw, T.Y. (2005). Decreased susceptibility of differentiated PC12 cells to oxidative challenge: relationship to cellular redox and expression of apoptotic protease activator factor-1. Cell Death Differ. 12, 1066–1077.10.1038/sj.cdd.4401650Suche in Google Scholar PubMed

Elias, E.G., Hasskamp, J.H., and Sharma, B.K. (2010). Cytokines and growth factors expressed by human cutaneous melanoma. Cancers 2, 794–808.10.3390/cancers2020794Suche in Google Scholar PubMed PubMed Central

Ellis, E.M. (2007). Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol. Ther. 115, 13–24.10.1016/j.pharmthera.2007.03.015Suche in Google Scholar PubMed

Estrela, J.M., Hernandez, R., Terradez, P., Asensi, M., Puertes, I.R., and Viña, J. (1992). Regulation of glutathione metabolism in Ehrlich ascites tumour cells. Biochem. J. 286, 257–262.10.1042/bj2860257Suche in Google Scholar PubMed PubMed Central

Estrela, J.M., Ortega, A., and Obrador, E. (2006). Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 43, 143–181.10.1080/10408360500523878Suche in Google Scholar PubMed

Estrela, J.M., Mena, S., Obrador, E., Benlloch, M., Castellano, G., Salvador, R., and Dellinger, R.W. (2017). Polyphenolic phytochemicals in cancer prevention and therapy: bioavailability versus bioefficacy. J. Med. Chem. 60, 9413–9436.10.1021/acs.jmedchem.6b01026Suche in Google Scholar PubMed

Farmer, P.J., Gidanian, S., Shahandeh, B., Di Bilio, A.J., Tohidian, N., and Meyskens, F.L. (2003). Melanin as a target for melanoma chemotherapy: pro-oxidant effect of oxygen and metals on melanoma viability. Pigment Cell Res. 16, 273–279.10.1034/j.1600-0749.2003.00046.xSuche in Google Scholar PubMed

Fecker, L.F., Eberle, J., Orfanos, C.E., and Geilen, C.C. (2002). Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide. J. Invest. Dermatol. 118, 1019–1025.10.1046/j.1523-1747.2002.01744.xSuche in Google Scholar PubMed

Filipp, F.V., Ratnikov, B., De Ingeniis, J., Smith, J.W., Osterman, A.L., and Scott, D.A. (2012). Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma. Pigment Cell Melanoma Res. 25, 732–739.10.1111/pcmr.12000Suche in Google Scholar PubMed PubMed Central

Fried, L. and Arbiser, J.L. (2008). The reactive oxygen-driven tumor: relevance to melanoma. Pigment Cell Melanoma Res. 21, 117–122.10.1111/j.1755-148X.2008.00451.xSuche in Google Scholar PubMed

Fruehauf, J.P. and Trapp, V. (2008). Reactive oxygen species: an Achilles’ heel of melanoma? Expert Rev. Anticancer Ther. 8, 1751–1757.10.1586/14737140.8.11.1751Suche in Google Scholar PubMed

Gidanian, S., Mentelle, M., Meyskens, F.L., and Farmer, P.J. (2008). Melanosomal damage in normal human melanocytes induced by UVB and metal uptake – a basis for the pro-oxidant state of melanoma. Photochem. Photobiol. 84, 556–564.10.1111/j.1751-1097.2008.00309.xSuche in Google Scholar PubMed PubMed Central

Gill, J.G., Piskounova, E., and Morrison, S.J. (2016). Cancer, oxidative stress, and metastasis. Cold Spring Harb. Symp. Quant. Biol. 81, 163–175.10.1101/sqb.2016.81.030791Suche in Google Scholar PubMed

Goodson, A.G., Cotter, M.A., Cassidy, P., Wade, M., Florell, S.R., Liu, T., Boucher, K.M., and Grossman, D. (2009). Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 15, 7434–7440.10.1158/1078-0432.CCR-09-1890Suche in Google Scholar PubMed PubMed Central

Govindarajan, B., Sligh, J.E., Vincent, B.J., Li, M., Canter, J.A., Nickoloff, B.J., Rodenburg, R.J., Smeitink, J.A., Oberley, L., Zhang, Y., et al. (2007). Overexpression of Akt converts radial growth melanoma to vertical growth melanoma. J. Clin. Invest. 117, 719–729.10.1172/JCI30102Suche in Google Scholar PubMed PubMed Central

Grammatico, P., Maresca, V., Roccella, F., Roccella, M., Biondo, L., Catricalà, C., and Picardo, M. (1998). Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients. Exp. Dermatol. 7, 205–212.10.1111/j.1600-0625.1998.tb00325.xSuche in Google Scholar PubMed

Grimm, E.A., Sikora, A.G., and Ekmekcioglu, S. (2013). Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 19, 5557–5563.10.1158/1078-0432.CCR-12-1554Suche in Google Scholar PubMed PubMed Central

Gu, Z., Wang, Q., Shi, Y., Huang, Y., Zhang, J., Zhang, X., and Lin, G. (2018). Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity. J. Control. Release Off. J. Control. Release Soc. 286, 369–380.10.1016/j.jconrel.2018.08.011Suche in Google Scholar PubMed

Gugler, R., Leschik, M., and Dengler, H.J. (1975). Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 9, 229–234.10.1007/BF00614022Suche in Google Scholar PubMed

Hajibabaei, K. (2016). The role of antioxidants and pro-oxidants in the prevention and treatment of cancers. Ann. Res. Antioxid. 1, e09.Suche in Google Scholar

Halestrap, A.P., Woodfield, K.Y., and Connern, C.P. (1997). Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J. Biol. Chem. 272, 3346–3354.10.1074/jbc.272.6.3346Suche in Google Scholar PubMed

Halliwell, B. (2006). Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 141, 312–322.10.1104/pp.106.077073Suche in Google Scholar

Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G.C., Frederick, D.T., Hurley, A.D., Nellore, A., Kung, A.L., et al. (2013). Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell 23, 302–315.10.1016/j.ccr.2013.02.003Suche in Google Scholar

Hegedüs, C., Kovács, K., Polgár, Z., Regdon, Z., Szabó, É., Robaszkiewicz, A., Forman, H.J., Martner, A., and Virág, L. (2018). Redox control of cancer cell destruction. Redox Biol. 16, 59–74.10.1016/j.redox.2018.01.015Suche in Google Scholar

Hertzman Johansson, C., Azimi, A., Frostvik Stolt, M., Shojaee, S., Wiberg, H., Grafström, E., Hansson, J., and Egyházi Brage, S. (2013). Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines. Melanoma Res. 23, 360–365.10.1097/CMR.0b013e328362f9cdSuche in Google Scholar

Hirose, K., Longo, D.L., Oppenheim, J.J., and Matsushima, K. (1993). Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 7, 361–368.10.1096/fasebj.7.2.8440412Suche in Google Scholar

Hirose, M., Takesada, Y., Tanaka, H., Tamano, S., Kato, T., and Shirai, T. (1998). Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model. Carcinogenesis 19, 207–212.10.1093/carcin/19.1.207Suche in Google Scholar

Hirose, M., Hoshiya, T., Mizoguchi, Y., Nakamura, A., Akagi, K., and Shirai, T. (2001). Green tea catechins enhance tumor development in the colon without effects in the lung or thyroid after pretreatment with 1,2-dimethylhydrazine or 2,2′-dihydroxy-di-n-propylnitrosamine in male F344 rats. Cancer Lett. 168, 23–29.10.1016/S0304-3835(01)00502-XSuche in Google Scholar

Hong, S.-K., Starenki, D., Wu, P.-K., and Park, J.-I. (2017). Suppression of B-RafV600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone. Cancer Biol. Ther. 18, 106–114.10.1080/15384047.2016.1250987Suche in Google Scholar PubMed PubMed Central

Hosseini, M., Kasraian, Z., and Rezvani, H.R. (2017). Energy metabolism in skin cancers: a therapeutic perspective. Biochim. Biophys. Acta 1858, 712–722.10.1016/j.bbabio.2017.01.013Suche in Google Scholar PubMed

Hsiao, P.-C., Chou, Y.-E., Tan, P., Lee, W.-J., Yang, S.-F., Chow, J.-M., Chen, H.-Y., Lin, C.-H., Lee, L.-M., and Chien, M.-H. (2014). Pterostilbene simultaneously induced G0/G1-phase arrest and MAPK-mediated mitochondrial-derived apoptosis in human acute myeloid leukemia cell lines. PLoS One 9, e105342.10.1371/journal.pone.0105342Suche in Google Scholar PubMed PubMed Central

Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., and Feng, Z. (2010). Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. USA 107, 7455–7460.10.1073/pnas.1001006107Suche in Google Scholar

Huang, H., Li, H., Yang, S., Chreifi, G., Martásek, P., Roman, L.J., Meyskens, F.L., Poulos, T.L., and Silverman, R.B. (2014). Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma. J. Med. Chem. 57, 686–700.10.1021/jm401252eSuche in Google Scholar

Hu-Lieskovan, S., Mok, S., Homet Moreno, B., Tsoi, J., Robert, L., Goedert, L., Pinheiro, E.M., Koya, R.C., Graeber, T.G., Comin-Anduix, B., et al. (2015). Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci. Transl. Med. 7, 279ra41.10.1126/scitranslmed.aaa4691Suche in Google Scholar

Jenkins, N.C. and Grossman, D. (2013). Role of melanin in melanocyte dysregulation of reactive oxygen species. BioMed Res. Int. 2013, 908797.10.1155/2013/908797Suche in Google Scholar

Jin, K., Li, T., van Dam, H., Zhou, F., and Zhang, L. (2017). Molecular insights into tumour metastasis: tracing the dominant events. J. Pathol. 241, 567–577.10.1002/path.4871Suche in Google Scholar

Jobe, N.P., Rösel, D., Dvořánková, B., Kodet, O., Lacina, L., Mateu, R., Smetana, K., and Brábek, J. (2016). Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness. Histochem. Cell Biol. 146, 205–217.10.1007/s00418-016-1433-8Suche in Google Scholar

Jones, D.P. and Sies, H. (2015). The redox code. Antioxid. Redox Signal. 23, 734–746.10.1089/ars.2015.6247Suche in Google Scholar

Kang, K.-H., Ling, T.-Y., Liou, H.-H., Huang, Y.-K., Hour, M.-J., Liou, H.-C., and Fu, W.-M. (2013). Enhancement role of host 12/15-lipoxygenase in melanoma progression. Eur. J. Cancer Oxf. Engl. 49, 2747–2759.10.1016/j.ejca.2013.03.030Suche in Google Scholar

Karg, E., Odh, G., Wittbjer, A., Rosengren, E., and Rorsman, H. (1993). Hydrogen peroxide as an inducer of elevated tyrosinase level in melanoma cells. J. Invest. Dermatol. 100, 209S–213S.10.1038/jid.1993.78Suche in Google Scholar

Kehrer, J.P. and Lund, L.G. (1994). Cellular reducing equivalents and oxidative stress. Free Radic. Biol. Med. 17, 65–75.10.1016/0891-5849(94)90008-6Suche in Google Scholar

Kelm, M. (1999). Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta 1411, 273–289.10.1016/S0005-2728(99)00020-1Suche in Google Scholar

Khamari, R., Trinh, A., Gabert, P.E., Corazao-Rozas, P., Riveros-Cruz, S., Balayssac, S., Malet-Martino, M., Dekiouk, S., Joncquel Chevalier Curt, M., Maboudou, P., et al. (2018). Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors. Cell Death Dis. 9, 325.10.1038/s41419-018-0340-4Suche in Google Scholar

Kim, H.-S., Quon, M.J., and Kim, J.-A. (2014). New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol. 2, 187–195.10.1016/j.redox.2013.12.022Suche in Google Scholar

Klimberg, V.S. and McClellan, J.L. (1996). Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy. Am. J. Surg. 172, 418–424.10.1016/S0002-9610(96)00217-6Suche in Google Scholar

Kondoh, M., Ohga, N., Akiyama, K., Hida, Y., Maishi, N., Towfik, A.M., Inoue, N., Shindoh, M., and Hida, K. (2013). Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment. PLoS One 8, e80349.10.1371/journal.pone.0080349Suche in Google Scholar

Kovacic, P. and Wakelin, L.P. (2001). Review: DNA molecular electrostatic potential: novel perspectives for the mechanism of action of anticancer drugs involving electron transfer and oxidative stress. Anticancer. Drug Des. 16, 175–184.Suche in Google Scholar

Krauthammer, M., Kong, Y., Ha, B.H., Evans, P., Bacchiocchi, A., McCusker, J.P., Cheng, E., Davis, M.J., Goh, G., Choi, M., et al. (2012). Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 44, 1006–1014.10.1038/ng.2359Suche in Google Scholar

Krebs, H.A. and Veech, R.L. (1969). Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv. Enzyme Regul. 7, 397–413.10.1016/0065-2571(69)90030-2Suche in Google Scholar

Kruk, J. and Aboul-Enein, H.Y. (2017). Reactive oxygen and nitrogen species in carcinogenesis: implications of oxidative stress on the progression and development of several cancer types. Mini Rev. Med. Chem. 17, 904–919.10.2174/1389557517666170228115324Suche in Google Scholar PubMed

Kubes, P., Suzuki, M., and Granger, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88, 4651–4655.10.1073/pnas.88.11.4651Suche in Google Scholar PubMed PubMed Central

Kumari, N., Dwarakanath, B.S., Das, A., and Bhatt, A.N. (2016). Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 37, 11553–11572.10.1007/s13277-016-5098-7Suche in Google Scholar PubMed

Kurosawa, K., Shibata, H., Hayashi, N., Sato, N., Kamada, T., and Tagawa, K. (1990). Kinetics of hydroperoxide degradation by NADP-glutathione system in mitochondria. J. Biochem. (Tokyo) 108, 9–16.10.1093/oxfordjournals.jbchem.a123169Suche in Google Scholar PubMed

Le Gal, K., Ibrahim, M.X., Wiel, C., Sayin, V.I., Akula, M.K., Karlsson, C., Dalin, M.G., Akyürek, L.M., Lindahl, P., Nilsson, J., et al. (2015). Antioxidants can increase melanoma metastasis in mice. Sci. Transl. Med. 7, 308re8.10.1126/scitranslmed.aad3740Suche in Google Scholar PubMed

Lee, D.J., Kang, D.H., Choi, M., Choi, Y.J., Lee, J.Y., Park, J.H., Park, Y.J., Lee, K.W., and Kang, S.W. (2013). Peroxiredoxin-2 represses melanoma metastasis by increasing E-cadherin/β-catenin complexes in adherens junctions. Cancer Res. 73, 4744–4757.10.1158/0008-5472.CAN-12-4226Suche in Google Scholar PubMed

Li, D., Ueta, E., Kimura, T., Yamamoto, T., and Osaki, T. (2004). Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci. 95, 644–650.10.1111/j.1349-7006.2004.tb03323.xSuche in Google Scholar PubMed

Li, C., Hu, Z., Liu, Z., Wang, L.-E., Gershenwald, J.E., Lee, J.E., Prieto, V.G., Duvic, M., Grimm, E.A., and Wei, Q. (2007). Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study. Cancer 109, 1570–1578.10.1002/cncr.22582Suche in Google Scholar PubMed

Li, W., Ma, J., Ma, Q., Li, B., Han, L., Liu, J., Xu, Q., Duan, W., Yu, S., Wang, F., et al. (2013). Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Curr. Med. Chem. 20, 4185–4194.10.2174/09298673113209990251Suche in Google Scholar PubMed PubMed Central

Li, W.-Q., Qureshi, A.A., Robinson, K.C., and Han, J. (2014). Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study. JAMA Intern. Med. 174, 964–970.10.1001/jamainternmed.2014.594Suche in Google Scholar PubMed PubMed Central

Li, H., Jiang, N., Liang, B., Liu, Q., Zhang, E., Peng, L., Deng, H., Li, R., Li, Z., and Zhu, H. (2017). Pterostilbene protects against UVB-induced photo-damage through a phosphatidylinositol-3-kinase-dependent Nrf2/ARE pathway in human keratinocytes. Redox Rep. Commun. Free Radic. Res. 22, 501–507.10.1080/13510002.2017.1329917Suche in Google Scholar PubMed PubMed Central

Lim, J.-H., Luo, C., Vazquez, F., and Puigserver, P. (2014). Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization. Cancer Res. 74, 3535–3545.10.1158/0008-5472.CAN-13-2893-TSuche in Google Scholar PubMed

Liou, G.-Y. and Storz, P. (2010). Reactive oxygen species in cancer. Free Radic. Res. 44, 479–496.10.3109/10715761003667554Suche in Google Scholar PubMed PubMed Central

Liu, F., Gomez Garcia, A.M., and Meyskens, F.L. (2012). NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells. J. Invest. Dermatol. 132, 2033–2041.10.1038/jid.2012.119Suche in Google Scholar PubMed

Liu, Q., Chen, F., Hou, L., Shen, L., Zhang, X., Wang, D., and Huang, L. (2018). Nanocarrier-mediated chemo-immunotherapy arrested cancer progression and induced tumor dormancy in desmoplastic melanoma. ACS Nano 12, 7812–7825.10.1021/acsnano.8b01890Suche in Google Scholar PubMed PubMed Central

Liu-Smith, F. and Ziogas, A. (2017). An age-dependent interaction between sex and geographical UV index in melanoma risk. J. Am. Acad. Dermatol. pii: S0190-9622(17)32748-2.Suche in Google Scholar

Liu-Smith, F., Dellinger, R., and Meyskens, F.L. (2014). Updates of reactive oxygen species in melanoma etiology and progression. Arch. Biochem. Biophys. 563, 51–55.10.1016/j.abb.2014.04.007Suche in Google Scholar PubMed PubMed Central

Liu-Smith, F., Poe, C., Farmer, P.J., and Meyskens, F.L. (2015). Amyloids, melanins and oxidative stress in melanomagenesis. Exp. Dermatol. 24, 171–174.10.1111/exd.12559Suche in Google Scholar PubMed PubMed Central

Liu-Smith, F., Farhat, A.M., Arce, A., Ziogas, A., Taylor, T., Wang, Z., Yourk, V., Liu, J., Wu, J., McEligot, A.J., et al. (2017). Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure. J. Am. Acad. Dermatol. 76, 499–505.e3.10.1016/j.jaad.2016.08.027Suche in Google Scholar PubMed PubMed Central

Loeb, S., Folkvaljon, Y., Lambe, M., Robinson, D., Garmo, H., Ingvar, C., and Stattin, P. (2015). Use of phosphodiesterase type 5 inhibitors for erectile dysfunction and risk of malignant melanoma. J. Am. Med. Assoc. 313, 2449–2455.10.1001/jama.2015.6604Suche in Google Scholar PubMed

Loeb, S., Ventimiglia, E., Salonia, A., Folkvaljon, Y., and Stattin, P. (2017). Meta-analysis of the association between phosphodiesterase inhibitors (PDE5Is) and risk of melanoma. J. Natl. Cancer Inst. 109, djx086. doi: 10.1093/jnci/djx086.10.1093/jnci/djx086Suche in Google Scholar PubMed PubMed Central

Lu, J. and Holmgren, A. (2014). The thioredoxin antioxidant system. Free Radic. Biol. Med. 66, 75–87.10.1016/j.freeradbiomed.2013.07.036Suche in Google Scholar PubMed

Luke, J.J., Flaherty, K.T., Ribas, A., and Long, G.V. (2017). Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat. Rev. Clin. Oncol. 14, 463–482.10.1038/nrclinonc.2017.43Suche in Google Scholar PubMed

Maes, H. and Agostinis, P. (2014). Autophagy and mitophagy interplay in melanoma progression. Mitochondrion 19 Pt A, 58–68.10.1016/j.mito.2014.07.003Suche in Google Scholar PubMed

Marchetti, P., Guerreschi, P., Kluza, J., and Mortier, L. (2014). Metabolic features of melanoma: a gold mine of new therapeutic targets? Curr. Cancer Drug Targets 14, 357–370.10.2174/1568009614666140407113124Suche in Google Scholar

Marchetti, P., Trinh, A., Khamari, R., and Kluza, J. (2018). Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors. Biochim. Biophys. Acta 1862, 999–1005.10.1016/j.bbagen.2018.01.018Suche in Google Scholar

Masuda, A., Longo, D.L., Kobayashi, Y., Appella, E., Oppenheim, J.J., and Matsushima, K. (1988). Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2, 3087–3091.10.1096/fasebj.2.15.3263930Suche in Google Scholar

Matthews, A., Langan, S.M., Douglas, I.J., Smeeth, L., and Bhaskaran, K. (2016). Phosphodiesterase type 5 inhibitors and risk of malignant melanoma: matched cohort study using primary care data from the UK clinical practice research datalink. PLoS Med. 13, e1002037.10.1371/journal.pmed.1002037Suche in Google Scholar

McNulty, S.E., del Rosario, R., Cen, D., Meyskens, F.L., and Yang, S. (2004). Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. Pigment Cell Res. 17, 173–180.10.1111/j.1600-0749.2004.00128.xSuche in Google Scholar

Meierjohann, S. (2014). Oxidative stress in melanocyte senescence and melanoma transformation. Eur. J. Cell Biol. 93, 36–41.10.1016/j.ejcb.2013.11.005Suche in Google Scholar

Meierjohann, S., Hufnagel, A., Wende, E., Kleinschmidt, M.A., Wolf, K., Friedl, P., Gaubatz, S., and Schartl, M. (2010). MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation. Mol. Cancer 9, 201.10.1186/1476-4598-9-201Suche in Google Scholar

Meister, A. (1991). Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51, 155–194.10.1016/0163-7258(91)90076-XSuche in Google Scholar

Melo, F.H.M., Molognoni, F., Morais, A.S., Toricelli, M., Mouro, M.G., Higa, E.M.S., Lopes, J.D., and Jasiulionis, M.G. (2011). Endothelial nitric oxide synthase uncoupling as a key mediator of melanocyte malignant transformation associated with sustained stress conditions. Free Radic. Biol. Med. 50, 1263–1273.10.1016/j.freeradbiomed.2011.02.022Suche in Google Scholar PubMed

Mena, S., Rodriguez, M.L., Ortega, A., Priego, S., Obrador, E., Asensi, M., Petschen, I., Cerdá, M., Brown, B.D., and Estrela, J.M. (2012). Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1. J. Transl. Med. 10, 8.10.1186/1479-5876-10-8Suche in Google Scholar PubMed PubMed Central

Meyskens, F.L. and Yang, S. (2011). Thinking about the role (largely ignored) of heavy metals in cancer prevention: hexavalent chromium and melanoma as a case in point. Recent Results Cancer Res. Fortschritte Krebsforsch. Progres Dans Rech. Sur Cancer 188, 65–74.10.1007/978-3-642-10858-7_5Suche in Google Scholar

Meyskens, F.L., Thomson, S.P., and Buckmeier, J. (1989). Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival. Clin. Exp. Metastasis 7, 627–632.10.1007/BF01753673Suche in Google Scholar

Meyskens, F.L., Chau, H.V., Tohidian, N., and Buckmeier, J. (1997). Luminol-enhanced chemiluminescent response of human melanocytes and melanoma cells to hydrogen peroxide stress. Pigment Cell Res. 10, 184–189.10.1111/j.1600-0749.1997.tb00482.xSuche in Google Scholar

Meyskens, F.L., Buckmeier, J.A., McNulty, S.E., and Tohidian, N.B. (1999). Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 5, 1197–1202.Suche in Google Scholar

Meyskens, F.L., McNulty, S.E., Buckmeier, J.A., Tohidian, N.B., Spillane, T.J., Kahlon, R.S., and Gonzalez, R.I. (2001). Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic. Biol. Med. 31, 799–808.10.1016/S0891-5849(01)00650-5Suche in Google Scholar

Milkovic, L., Siems, W., Siems, R., and Zarkovic, N. (2014). Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer. Curr. Pharm. Des. 20, 6529–6542.10.2174/1381612820666140826152822Suche in Google Scholar PubMed

Mishra, H., Mishra, P.K., Ekielski, A., Jaggi, M., Iqbal, Z., and Talegaonkar, S. (2018). Melanoma treatment: from conventional to nanotechnology. J. Cancer Res. Clin. Oncol. doi: 10.1007/s00432-018-2726-1. [Epub ahead of print].10.1007/s00432-018-2726-1Suche in Google Scholar PubMed

Miura, K. and Green, A.C. (2015). Dietary antioxidants and melanoma: evidence from cohort and intervention studies. Nutr. Cancer 67, 867–876.10.1080/01635581.2015.1053499Suche in Google Scholar PubMed

Moreno-Smith, M., Lutgendorf, S.K., and Sood, A.K. (2010). Impact of stress on cancer metastasis. Future Oncol. Lond. Engl. 6, 1863–1881.10.2217/fon.10.142Suche in Google Scholar PubMed PubMed Central

Mourah, S., Denis, M.G., Narducci, F.E., Solassol, J., Merlin, J.-L., Sabourin, J.-C., Scoazec, J.-Y., Ouafik, L., Emile, J.-F., Heller, R., et al. (2015). Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting. PLoS One 10, e0120232.10.1371/journal.pone.0120232Suche in Google Scholar PubMed PubMed Central

Na, Y.-R., Lee, J.-S., Lee, S.-J., and Seok, S.-H. (2013). Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis. Melanoma Res. 23, 434–443.10.1097/CMR.0000000000000021Suche in Google Scholar PubMed

New, L.-S. and Chan, E.C.Y. (2008). Evaluation of BEH C18, BEH HILIC, and HSS T3 (C18) column chemistries for the UPLC-MS-MS analysis of glutathione, glutathione disulfide, and ophthalmic acid in mouse liver and human plasma. J. Chromatogr. Sci. 46, 209–214.10.1093/chromsci/46.3.209Suche in Google Scholar

Nicolussi, A., D’Inzeo, S., Capalbo, C., Giannini, G., and Coppa, A. (2017). The role of peroxiredoxins in cancer. Mol. Clin. Oncol. 6, 139–153.10.3892/mco.2017.1129Suche in Google Scholar

Nihal, M., Ahsan, H., Siddiqui, I.A., Mukhtar, H., Ahmad, N., and Wood, G.S. (2009). (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma. Cell Cycle Georget. Tex 8, 2057–2063.10.4161/cc.8.13.8862Suche in Google Scholar

Nishida, M., Kumagai, Y., Ihara, H., Fujii, S., Motohashi, H., and Akaike, T. (2016). Redox signaling regulated by electrophiles and reactive sulfur species. J. Clin. Biochem. Nutr. 58, 91–98.10.3164/jcbn.15-111Suche in Google Scholar

Obrador, E., Carretero, J., Esteve, J.M., Pellicer, J.A., Pascual, A., Petschen, I., and Estrela, J.M. (2001). Glutamine potentiates TNF-alpha-induced tumor cytotoxicity. Free Radic. Biol. Med. 31, 642–650.10.1016/S0891-5849(01)00622-0Suche in Google Scholar

Obrador, E., Carretero, J., Ortega, A., Medina, I., Rodilla, V., Pellicer, J.A., and Estrela, J.M. (2002). Gamma-glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatol. Baltim. Md 35, 74–81.10.1053/jhep.2002.30277Suche in Google Scholar PubMed

Obrador, E., Benlloch, M., Pellicer, J.A., Asensi, M., and Estrela, J.M. (2011). Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice. J. Biol. Chem. 286, 15716–15727.10.1074/jbc.M110.196261Suche in Google Scholar PubMed PubMed Central

Obrador, E., Valles, S.L., Benlloch, M., Sirerol, J.A., Pellicer, J.A., Alcácer, J., Coronado, J.A.-F., and Estrela, J.M. (2014). Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity. PLoS One 9, e96466.10.1371/journal.pone.0096466Suche in Google Scholar PubMed PubMed Central

Omenn, G.S., Goodman, G.E., Thornquist, M.D., Balmes, J., Cullen, M.R., Glass, A., Keogh, J.P., Meyskens, F.L., Valanis, B., Williams, J.H., et al. (1996). Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 88, 1550–1559.10.1093/jnci/88.21.1550Suche in Google Scholar PubMed

Onkoksoong, T., Jeayeng, S., Poungvarin, N., Limsaengurai, S., Thamsermsang, O., Tripatara, P., Akarasereenont, P., and Panich, U. (2018). Thai herbal antipyretic 22 formula (APF22) inhibits UVA-mediated melanogenesis through activation of Nrf2-regulated antioxidant defense. Phytother. Res. PTR 32, 1546–1554.10.1002/ptr.6083Suche in Google Scholar PubMed

Ortega, A., Ferrer, P., Carretero, J., Obrador, E., Asensi, M., Pellicer, J.A., and Estrela, J.M. (2003). Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. J. Biol. Chem. 278, 39591–39599.10.1074/jbc.M303753200Suche in Google Scholar

Pal, H.C., Sharma, S., Strickland, L.R., Katiyar, S.K., Ballestas, M.E., Athar, M., Elmets, C.A., and Afaq, F. (2014). Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways. PLoS One 9, e86338.10.1371/journal.pone.0086338Suche in Google Scholar

Pal, H.C., Baxter, R.D., Hunt, K.M., Agarwal, J., Elmets, C.A., Athar, M., and Afaq, F. (2015). Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells. Oncotarget 6, 28296–28311.10.18632/oncotarget.5064Suche in Google Scholar

Pavel, S., van Nieuwpoort, F., van der Meulen, H., Out, C., Pizinger, K., Cetkovská, P., Smit, N.P.M., and Koerten, H.K. (2004). Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi. Eur. J. Cancer Oxf. Engl. 40, 1423–1430.10.1016/j.ejca.2003.11.035Suche in Google Scholar

Payne, A.S. and Cornelius, L.A. (2002). The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 118, 915–922.10.1046/j.1523-1747.2002.01725.xSuche in Google Scholar

Piskounova, E., Agathocleous, M., Murphy, M.M., Hu, Z., Huddlestun, S.E., Zhao, Z., Leitch, A.M., Johnson, T.M., DeBerardinis, R.J., and Morrison, S.J. (2015). Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186–191.10.1038/nature15726Suche in Google Scholar

Prasad, R., Kappes, J.C., and Katiyar, S.K. (2016). Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells. Oncotarget 7, 7899–7912.10.18632/oncotarget.6860Suche in Google Scholar

Rabender, C.S., Alam, A., Sundaresan, G., Cardnell, R.J., Yakovlev, V.A., Mukhopadhyay, N.D., Graves, P., Zweit, J., and Mikkelsen, R.B. (2015). The role of nitric oxide synthase uncoupling in tumor progression. Mol. Cancer Res. MCR 13, 1034–1043.10.1158/1541-7786.MCR-15-0057-TSuche in Google Scholar

Ray, P.D., Huang, B.-W., and Tsuji, Y. (2012). Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24, 981–990.10.1016/j.cellsig.2012.01.008Suche in Google Scholar

Reich, R. and Martin, G.R. (1996). Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells. Prostaglandins 51, 1–17.10.1016/0090-6980(95)00154-9Suche in Google Scholar

Rhodes, A.R., Seki, Y., Fitzpatrick, T.B., and Stern, R.S. (1988). Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. Cancer 61, 358–369.10.1002/1097-0142(19880115)61:2<358::AID-CNCR2820610227>3.0.CO;2-#Suche in Google Scholar

Ribeiro-Pereira, C., Moraes, J.A., Souza, M. de J., Laurindo, F.R., Arruda, M.A., and Barja-Fidalgo, C. (2014). Redox modulation of FAK controls melanoma survival – role of NOX4. PLoS One 9, e99481.10.1371/journal.pone.0099481Suche in Google Scholar

Richmond, A. (1991). The pathogenic role of growth factors in melanoma. Semin. Dermatol. 10, 246–255.Suche in Google Scholar

Rozeman, E.A., Dekker, T.J.A., Haanen, J.B.A.G., and Blank, C.U. (2018). Advanced melanoma: current treatment options, biomarkers, and future perspectives. Am. J. Clin. Dermatol. 19, 303–317.10.1007/s40257-017-0325-6Suche in Google Scholar

Sabharwal, S.S. and Schumacker, P.T. (2014). Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat. Rev. Cancer 14, 709–721.10.1038/nrc3803Suche in Google Scholar

Saleem, M., Maddodi, N., Abu Zaid, M., Khan, N., bin Hafeez, B., Asim, M., Suh, Y., Yun, J.-M., Setaluri, V., and Mukhtar, H. (2008). Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 14, 2119–2127.10.1158/1078-0432.CCR-07-4413Suche in Google Scholar

Salimian Rizi, B., Achreja, A., and Nagrath, D. (2017). Nitric oxide: the forgotten child of tumor metabolism. Trends Cancer 3, 659–672.10.1016/j.trecan.2017.07.005Suche in Google Scholar

Sander, C.S., Hamm, F., Elsner, P., and Thiele, J.J. (2003). Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br. J. Dermatol. 148, 913–922.10.1046/j.1365-2133.2003.05303.xSuche in Google Scholar

Sander, C.S., Chang, H., Hamm, F., Elsner, P., and Thiele, J.J. (2004). Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int. J. Dermatol. 43, 326–335.10.1111/j.1365-4632.2004.02222.xSuche in Google Scholar

Santos Bernardes, S., de Souza-Neto, F.P., Pasqual Melo, G., Guarnier, F.A., Marinello, P.C., Cecchini, R., and Cecchini, A.L. (2016). Correlation of TGF-β1 and oxidative stress in the blood of patients with melanoma: a clue to understanding melanoma progression? Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med. 37, 10753–10761.10.1007/s13277-016-4967-4Suche in Google Scholar

Saw, C.L.L., Guo, Y., Yang, A.Y., Paredes-Gonzalez, X., Ramirez, C., Pung, D., and Kong, A.-N.T. (2014). The berry constituents quercetin, kaempferol, and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 72, 303–311.10.1016/j.fct.2014.07.038Suche in Google Scholar

Scalise, M., Pochini, L., Galluccio, M., Console, L., and Indiveri, C. (2017). Glutamine transport and mitochondrial metabolism in cancer cell growth. Front. Oncol. 7, 306.10.3389/fonc.2017.00306Suche in Google Scholar

Scheit, K. and Bauer, G. (2015). Direct and indirect inactivation of tumor cell protective catalase by salicylic acid and anthocyanidins reactivates intercellular ROS signaling and allows for synergistic effects. Carcinogenesis 36, 400–411.10.1093/carcin/bgv010Suche in Google Scholar

Schmitt, A., Schmitz, W., Hufnagel, A., Schartl, M., and Meierjohann, S. (2015). Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling. Biochem. J. 471, 267–279.10.1042/BJ20141204Suche in Google Scholar

Schönfeld, P., Bohnensack, R., Böhme, G., and Kunz, W. (1983). Influence of the beta-hydroxybutyrate/acetoacetate ratio on the redox states of mitochondrial NAD(P) and cytochrome c systems, extramitochondrial ATP/ADP ratio and the respiration of isolated liver mitochondria in the resting state. Biomed. Biochim. Acta 42, 3–13.Suche in Google Scholar

Shain, A.H. and Bastian, B.C. (2016). From melanocytes to melanomas. Nat. Rev. Cancer 16, 345–358.10.1038/nrc.2016.37Suche in Google Scholar

Shao, Q., Xu, Z., Wang, J., Shi, J., and Zhu, W. (2017). Energetics and structural characterization of the ‘DFG-flip’ conformational transition of B-RAF kinase: a SITS molecular dynamics study. Phys. Chem. Chem. Phys. PCCP 19, 1257–1267.10.1039/C6CP06624KSuche in Google Scholar

Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Exp. Physiol. 82, 291–295.10.1113/expphysiol.1997.sp004024Suche in Google Scholar

Sies, H. and Cadenas, E. (1985). Oxidative stress: damage to intact cells and organs. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 311, 617–631.10.1098/rstb.1985.0168Suche in Google Scholar

Sies, H. and de Groot, H. (1992). Role of reactive oxygen species in cell toxicity. Toxicol. Lett. 64–65 Spec No, 547–551.10.1016/0378-4274(92)90230-HSuche in Google Scholar

Sies, H., Brigelius, R., Wefers, H., Müller, A., and Cadenas, E. (1983). Cellular redox changes and response to drugs and toxic agents. Fundam. Appl. Toxicol. Off. J. Soc. Toxicol. 3, 200–208.10.1093/toxsci/3.4.200Suche in Google Scholar

Sies, H., Berndt, C., and Jones, D.P. (2017). Oxidative stress. Annu. Rev. Biochem. 86, 715–748.10.1146/annurev-biochem-061516-045037Suche in Google Scholar PubMed

Sikora, A.G., Gelbard, A., Davies, M.A., Sano, D., Ekmekcioglu, S., Kwon, J., Hailemichael, Y., Jayaraman, P., Myers, J.N., Grimm, E.A., et al. (2010). Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 16, 1834–1844.10.1158/1078-0432.CCR-09-3123Suche in Google Scholar PubMed PubMed Central

Sinnya, S. and De’Ambrosis, B. (2013). Stress and melanoma: increasing the evidence towards a causal basis. Arch. Dermatol. Res. 305, 851–856.10.1007/s00403-013-1373-2Suche in Google Scholar PubMed

Soengas, M.S. (2012). Mitophagy or how to control the Jekyll and Hyde embedded in mitochondrial metabolism: implications for melanoma progression and drug resistance. Pigment Cell Melanoma Res. 25, 721–731.10.1111/pcmr.12021Suche in Google Scholar PubMed

Stafford, W.C., Peng, X., Olofsson, M.H., Zhang, X., Luci, D.K., Lu, L., Cheng, Q., Trésaugues, L., Dexheimer, T.S., Coussens, N.P., et al. (2018). Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci. Transl. Med. 10. pii: eaaf7444.10.1126/scitranslmed.aaf7444Suche in Google Scholar PubMed PubMed Central

Suresh, A., Guedez, L., Moreb, J., and Zucali, J. (2003). Overexpression of manganese superoxide dismutase promotes survival in cell lines after doxorubicin treatment. Br. J. Haematol. 120, 457–463.10.1046/j.1365-2141.2003.04074.xSuche in Google Scholar PubMed

Syed, D.N., Afaq, F., Maddodi, N., Johnson, J.J., Sarfaraz, S., Ahmad, A., Setaluri, V., and Mukhtar, H. (2011). Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. J. Invest. Dermatol. 131, 1291–1299.10.1038/jid.2011.6Suche in Google Scholar PubMed PubMed Central

Szatrowski, T.P. and Nathan, C.F. (1991). Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794–798.Suche in Google Scholar

Szczepaniak Sloane, R.A., Gopalakrishnan, V., Reddy, S.M., Zhang, X., Reuben, A., and Wargo, J.A. (2017). Interaction of molecular alterations with immune response in melanoma. Cancer 123, 2130–2142.10.1002/cncr.30681Suche in Google Scholar PubMed PubMed Central

Tanese, K., Grimm, E.A., and Ekmekcioglu, S. (2012). The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10. Int. J. Cancer 131, 891–901.10.1002/ijc.26451Suche in Google Scholar PubMed PubMed Central

Tarapore, R.S., Siddiqui, I.A., Saleem, M., Adhami, V.M., Spiegelman, V.S., and Mukhtar, H. (2010). Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol. Carcinogenesis 31, 1844–1853.10.1093/carcin/bgq169Suche in Google Scholar PubMed PubMed Central

Theodosakis, N., Micevic, G., Kelly, D.P., and Bosenberg, M. (2014). Mitochondrial function in melanoma. Arch. Biochem. Biophys. 563, 56–59.10.1016/j.abb.2014.06.028Suche in Google Scholar PubMed

Trisciuoglio, D., Desideri, M., Ciuffreda, L., Mottolese, M., Ribatti, D., Vacca, A., Del Rosso, M., Marcocci, L., Zupi, G., and Del Bufalo, D. (2005). Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth. J. Cell. Physiol. 205, 414–421.10.1002/jcp.20413Suche in Google Scholar PubMed

Tsai, M.-L., Lai, C.-S., Chang, Y.-H., Chen, W.-J., Ho, C.-T., and Pan, M.-H. (2012). Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis. Food Funct. 3, 1185–1194.10.1039/c2fo30105aSuche in Google Scholar PubMed

Tsung, A.J., Kargiotis, O., Chetty, C., Lakka, S.S., Gujrati, M., Spomar, D.G., Dinh, D.H., and Rao, J.S. (2008). Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model. Int. J. Oncol. 32, 557–564.10.3892/ijo.32.3.557Suche in Google Scholar

Uetaki, M., Tabata, S., Nakasuka, F., Soga, T., and Tomita, M. (2015). Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress. Sci. Rep. 5, 13896.10.1038/srep13896Suche in Google Scholar PubMed PubMed Central

Vaccaro, M., Irrera, N., Cutroneo, G., Rizzo, G., Vaccaro, F., Anastasi, G.P., Borgia, F., Cannavò, S.P., Altavilla, D., and Squadrito, F. (2017). Differential expression of nitric oxide synthase isoforms nNOS and iNOS in patients with non-segmental generalized vitiligo. Int. J. Mol. Sci. 18. pii: E2533.10.3390/ijms18122533Suche in Google Scholar PubMed PubMed Central

Väisänen, A.H., Kallioinen, M., and Turpeenniemi-Hujanen, T. (2008). Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma. Hum. Pathol. 39, 377–385.10.1016/j.humpath.2007.06.021Suche in Google Scholar PubMed

Valko, M., Jomova, K., Rhodes, C.J., Kuča, K., and Musílek, K. (2016). Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch. Toxicol. 90, 1–37.10.1007/s00204-015-1579-5Suche in Google Scholar PubMed

Valles, S.L., Benlloch, M., Rodriguez, M.L., Mena, S., Pellicer, J.A., Asensi, M., Obrador, E., and Estrela, J.M. (2013). Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J. Transl. Med. 11, 72.10.1186/1479-5876-11-72Suche in Google Scholar PubMed PubMed Central

Vazquez, F., Lim, J.-H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C.B., Granter, S.R., Widlund, H.R., Spiegelman, B.M., et al. (2013). PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23, 287–301.10.1016/j.ccr.2012.11.020Suche in Google Scholar PubMed PubMed Central

Vinceti, M., Dennert, G., Crespi, C.M., Zwahlen, M., Brinkman, M., Zeegers, M.P., Horneber, M., D’Amico, R., and Del Giovane, C. (2014). Selenium for preventing cancer. Cochrane Database Syst. Rev. CD005195. doi: 10.1002/14651858.CD005195.pub3.10.1002/14651858.CD005195.pub3Suche in Google Scholar PubMed PubMed Central

Wang, Y., Yang, F., Zhang, H.X., Zi, X.Y., Pan, X.H., Chen, F., Luo, W.D., Li, J.X., Zhu, H.Y., and Hu, Y.P. (2013). Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria. Cell Death Dis. 4, e783.10.1038/cddis.2013.314Suche in Google Scholar PubMed PubMed Central

Wang, S.D., Wang, Z.H., Yan, H.Q., Ren, M.Y., Gao, S.Q., and Zhang, G.Q. (2016). Chemotherapeutic effect of Zerumbone on melanoma cells through mitochondria-mediated pathways. Clin. Exp. Dermatol. 41, 858–863.10.1111/ced.12986Suche in Google Scholar PubMed

Wang, L., Leite de Oliveira, R., Huijberts, S., Bosdriesz, E., Pencheva, N., Brunen, D., Bosma, A., Song, J.-Y., Zevenhoven, J., Los-de Vries, G.T., et al. (2018). An acquired vulnerability of drug-resistant melanoma with therapeutic potential. Cell 173, 1413–1425.e14.10.1016/j.cell.2018.04.012Suche in Google Scholar PubMed

Weinstein, D., Leininger, J., Hamby, C., and Safai, B. (2014). Diagnostic and prognostic biomarkers in melanoma. J. Clin. Aesthetic Dermatol. 7, 13–24.Suche in Google Scholar

Winer, I., Normolle, D.P., Shureiqi, I., Sondak, V.K., Johnson, T., Su, L., and Brenner, D.E. (2002). Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis. Melanoma Res. 12, 429–434.10.1097/00008390-200209000-00003Suche in Google Scholar PubMed

Wittgen, H.G.M. and van Kempen, L.C.L.T. (2007). Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res. 17, 400–409.10.1097/CMR.0b013e3282f1d312Suche in Google Scholar PubMed

Witting, N., Kruuse, C., Nyhuus, B., Prahm, K.P., Citirak, G., Lundgaard, S.J., von Huth, S., Vejlstrup, N., Lindberg, U., Krag, T.O., et al. (2014). Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy. Ann. Neurol. 76, 550–557.10.1002/ana.24216Suche in Google Scholar PubMed

Woźniak, A., Drewa, G., Woźniak, B., and Schachtschabel, D.O. (2004). Activity of antioxidant enzymes and concentration of lipid peroxidation products in selected tissues of mice of different ages, both healthy and melanoma-bearing. Z. Gerontol. Geriatr. 37, 184–189.10.1007/s00391-004-0229-ySuche in Google Scholar PubMed

Xia, J., Du, Y., Huang, L., Chaurasiya, B., Tu, J., Webster, T.J., and Sun, C. (2018a). Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma. Nanomedicine Nanotechnol. Biol. Med. 14, 713–723.10.1016/j.nano.2017.12.017Suche in Google Scholar PubMed

Xia, Y., Xu, T., Wang, C., Li, Y., Lin, Z., Zhao, M., and Zhu, B. (2018b). Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy. Int. J. Nanomedicine 13, 143–159.10.2147/IJN.S148960Suche in Google Scholar PubMed PubMed Central

Xiang, L., Xie, G., Liu, C., Zhou, J., Chen, J., Yu, S., Li, J., Pang, X., Shi, H., and Liang, H. (2013). Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation. Biochim. Biophys. Acta 1833, 2996–3005.10.1016/j.bbamcr.2013.08.003Suche in Google Scholar PubMed

Xie, T., Nguyen, T., Hupe, M., and Wei, M.L. (2009). Multidrug resistance decreases with mutations of melanosomal regulatory genes. Cancer Res. 69, 992–999.10.1158/0008-5472.CAN-08-0506Suche in Google Scholar

Yamanishi, D.T., Buckmeier, J.A., and Meyskens, F.L. (1991). Expression of c-jun, jun-B, and c-fos proto-oncogenes in human primary melanocytes and metastatic melanomas. J. Invest. Dermatol. 97, 349–353.10.1111/1523-1747.ep12480698Suche in Google Scholar

Yamaura, M., Mitsushita, J., Furuta, S., Kiniwa, Y., Ashida, A., Goto, Y., Shang, W.H., Kubodera, M., Kato, M., Takata, M., et al. (2009). NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res. 69, 2647–2654.10.1158/0008-5472.CAN-08-3745Suche in Google Scholar

Yang, E.V., Kim, S., Donovan, E.L., Chen, M., Gross, A.C., Webster Marketon, J.I., Barsky, S.H., and Glaser, R. (2009). Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain. Behav. Immun. 23, 267–275.10.1016/j.bbi.2008.10.005Suche in Google Scholar

Yang, Z., Misner, B., Ji, H., Poulos, T.L., Silverman, R.B., Meyskens, F.L., and Yang, S. (2013). Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma. Antioxid. Redox Signal. 19, 433–447.10.1089/ars.2012.4563Suche in Google Scholar

Yang, G., Yan, Y., Ma, Y., and Yang, Y. (2017). Vitamin C at high concentrations induces cytotoxicity in malignant melanoma but promotes tumor growth at low concentrations. Mol. Carcinog. 56, 1965–1976.10.1002/mc.22654Suche in Google Scholar

Yu, C., Yap, N., Chen, D., and Cheng, S. (1997). Modulation of hormone-dependent transcriptional activity of the glucocorticoid receptor by the tumor suppressor p53. Cancer Lett. 116, 191–196.10.1016/S0304-3835(97)00186-9Suche in Google Scholar

Yu, L., Gao, L.X., Ma, X.Q., Hu, F.X., Li, C.M., and Lu, Z. (2014). Involvement of superoxide and nitric oxide in BRAF(V600E) inhibitor PLX4032-induced growth inhibition of melanoma cells. Integr. Biol. Quant. Biosci. Nano Macro 6, 1211–1217.10.1039/C4IB00170BSuche in Google Scholar

Yuan, T.-A., Yourk, V., Farhat, A., Ziogas, A., Meyskens, F.L., Anton-Culver, H., and Liu-Smith, F. (2018). A case-control study of the genetic variability in reactive oxygen species-metabolizing enzymes in melanoma risk. Int. J. Mol. Sci. 19. pii: E242.10.3390/ijms19010242Suche in Google Scholar PubMed PubMed Central

Zhao, Y., Guo, X., Ma, Z., Gu, L., Ge, J., and Li, Q. (2011). Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells. Med. Oncol. Northwood Lond. Engl. 28, 1609–1617.10.1007/s12032-010-9641-xSuche in Google Scholar PubMed

Zhu, B.T. and Liehr, J.G. (1994). Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol. 125, 149–158.10.1006/taap.1994.1059Suche in Google Scholar PubMed